In-Depth View Of Over 1600 Deals And Alliances Announced In Infectious Diseases Between 2001 And 2006
Research and Markets (http://www.researchandmarkets.com/reports/c45488) has announced the addition of “Partneringdesk Deals and alliances in infectious diseases” to their offering.
Partneringdesk deals and alliances in infectious diseases provides an in-depth view of over 1600 deals and alliances announced in infectious diseases between 2001 and 2006, in a clear and accessible PDF format.
Report Includes:
Fully categorized deal overviews
Financial information where disclosed
Company profiles of the top 25 dealmakers in the report
Specialized indexes by company, development stage, deal type and industry sector.
Wider coverage of Japanese deals courtesy of JCN
Reasons to Purchase
This report will help in:
The assessment of deal-making trends in the last five years
Identifying active partners
Tracking competitor activity
Benchmarking deals
Who should buy the report
This report is essential reading for board and executive management, and individuals in:
Business development
licensing/partnering
Deal making
Business strategy
Marketing and promotion
Distribution and manufacturing (including contract services)
Topics Covered:
About Partneringdesk deals and alliances
Deals in infectious diseases by company
Deals in infectious diseases by development stage
Deals in infectious diseases by type
Deals in infectious diseases by industry sector
Summary profiles for the most active companies in infectious diseases
List of deals
Companies Mentioned:
Abbott Laboratories
Aventis
Beckman Coulter Inc
Boehringer Ingelheim GmbH
Calypte Biomedical Corp
Cangene
CEL- SCI Corp
Centers for Disease Control and Prevention
Chiron Corp
CombiMatrix
Corixa
Crucell
Gilead Sciences Inc
GlaxoSmithKline
Hemispherx BioPharma Inc
InterMune
International AIDS Vaccine Initiative
Medicines for Malaria Venture
Merck & Co Inc
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Roche
US Army Medical Research Institute of Infectious Diseases
VaxGen Inc
ViroLogic
For more information visit http://www.researchandmarkets.com/reports/c45488